| Trial ID: | L4592 |
| Source ID: | NCT01429818
|
| Associated Drug: |
Glimepiride/Metformin
|
| Title: |
Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Endothelial Dysfunction|Diabetes Mellitus
|
| Interventions: |
DRUG: Glimepiride/metformin|DRUG: Metformin
|
| Outcome Measures: |
Primary: EDVI, endothelial-dependent vasodilation index, 8 weeks|MFR, myocardial flow reserve, 8 weeks|%ΔMBF, percentage of the change between rest and CPT, 8 weeks | Secondary: Fasting glucose, 8 weeks|Glycated hemoglobin, 8 weeks|Adverse effects, 8 weeks
|
| Sponsor/Collaborators: |
Sponsor: Laboratorios Silanes S.A. de C.V.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-07
|
| Completion Date: |
2008-01
|
| Results First Posted: |
|
| Last Update Posted: |
2011-09-07
|
| Locations: |
Unidad PET Ciclotrón. Facultad de Medicina. Universidad Nacional Autónoma de México, Mexico city, Distrito Federal, 04510, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT01429818
|
